Bert Vogelstein

12.6k total citations · 3 hit papers
16 papers, 10.6k citations indexed

About

Bert Vogelstein is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Bert Vogelstein has authored 16 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Bert Vogelstein's work include Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (5 papers) and Neuroblastoma Research and Treatments (4 papers). Bert Vogelstein is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (5 papers) and Neuroblastoma Research and Treatments (4 papers). Bert Vogelstein collaborates with scholars based in United States, United Kingdom and Australia. Bert Vogelstein's co-authors include K W Kinzler, Victor E. Velculescu, J.M. Trent, David Pei‐Cheng Lin, Daniel B. Levy, Ramon Parsons, Takashi Tokino, Wafik S. El‐Deiry, W E Mercer and Kathleen R. Cho and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Bert Vogelstein

16 papers receiving 10.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

WAF1, a potential mediator of p53 tumor suppression

1993 7.2k citations Wafik S. El‐Deiry, Takashi Tokino et al. Cell profile →
APC mutations occur early during colorectal tumorigenesis

1992 1.5k citations Tracy M. Bryan, Stanley R. Hamilton et al. Nature profile →
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers

1996 501 citations Sam Thiagalingam, Christoph Lengauer et al. Nature Genetics profile →

Peers

Countries citing papers authored by Bert Vogelstein

Since Specialization

Citations

This map shows the geographic impact of Bert Vogelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Vogelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Vogelstein more than expected).

Fields of papers citing papers by Bert Vogelstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bert Vogelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Vogelstein. The network helps show where Bert Vogelstein may publish in the future.

Co-authorship network of co-authors of Bert Vogelstein

This figure shows the co-authorship network connecting the top 25 collaborators of Bert Vogelstein. A scholar is included among the top collaborators of Bert Vogelstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bert Vogelstein. Bert Vogelstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	318MO Circulating tumour DNA (ctDNA) dynamics, CEA and sites of recurrence for the randomised DYNAMIC study: Adjuvant chemotherapy (ACT) guided by ctDNA analysis in stage II colon cancer (CC) 2022 ·Annals of Oncology ·Jeanne Tie, Jesse Cohen, Kamel Lahouel, Serigne Lo, Y. Wang, Rachel Wong, Jeremy Shapiro, Sam Harris, Adnan Khattak, (unknown), Lisa G. Horvath, Christos S. Karapetis, J. Shannon, Madhu Singh, (unknown), Nikolaos G. Papadopoulos, Cristian Tomasetti, K. W. Kinzler, Bert Vogelstein, Peter Gibbs	8
2	Analysing uncharted transcriptomes with SAGE 2000 ·Trends in Genetics ·Victor E. Velculescu, Bert Vogelstein, Kenneth W. Kinzler	142
3	Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers breakdown → 1996 ·Nature Genetics ·Sam Thiagalingam, Christoph Lengauer, (unknown), Mieke Schutte, Stephan A. Hahn, Joan Overhauser, James K. V. Willson, Sanford D. Markowitz, Stanley R. Hamilton, Scott E. Kern, K W Kinzler, Bert Vogelstein	501
4	The DCC Gene: Structural Analysis and Mutations in Colorectal Carcinomas 1994 ·Genomics ·Kathleen R. Cho, (unknown), Jonathan W. Simons, Lora Hedrick, Eric R. Fearon, Antonette C. Preisinger, Philip Hedge, Gary A. Silverman, Bert Vogelstein	172
5	WAF1, a potential mediator of p53 tumor suppression breakdown → 1993 ·Cell ·Wafik S. El‐Deiry, Takashi Tokino, Victor E. Velculescu, Daniel B. Levy, Ramon Parsons, J.M. Trent, David Pei‐Cheng Lin, W E Mercer, K W Kinzler, Bert Vogelstein	7234
6	Cell adhesion molecules as tumour suppressors 1993 ·Trends in Cell Biology ·Lora Hedrick, Kathleen R. Cho, Bert Vogelstein	64
7	APC mutations occur early during colorectal tumorigenesis breakdown → 1992 ·Nature ·(unknown), (unknown), (unknown), Tracy M. Bryan, Stanley R. Hamilton, Stephen N. Thibodeau, Bert Vogelstein, K. W. Kinzler	1493
8	Mutational Spectra and Immunohistochemical Analyses of p53 in Human Cancers 1992 ·CHEST Journal ·William P. Bennett, Monica Hollstein, Ih‐Chang Hsu, David Sidransky, David P. Lane, Bert Vogelstein, C C Harris	26
9	Genetic alterations in the adenoma–carcinoma sequence 1992 ·Cancer ·Kathleen R. Cho, Bert Vogelstein	306
10	REPORTS 1991 ·JNCI Journal of the National Cancer Institute ·John S. Kovach, Renee M. McGovern, Joslyn Cassady, Selene K. Swanson, Lester E. Wold, Bert Vogelstein, Steve S. Sommer	80
11	Infrequent p53 gene mutations in medulloblastomas. 1991 ·PubMed ·Robert L. Saylors, David Sidransky, H. S. Friedman, Sandra H. Bigner, Bigner Dd, Bert Vogelstein, G M Brodeur	163
12	Yeast artificial chromosome (YAC) vector cloning of the MYCN amplified domain in neuroblastomas. 1991 ·PubMed ·Sandra Schneider, Barbara A. Zehnbauer, Bert Vogelstein, G M Brodeur	5
13	Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. 1990 ·PubMed ·Sandra H. Bigner, Peter A. Humphrey, Albert J. Wong, Bert Vogelstein, Joachim Mark, Henry S. Friedman, D D Bigner	275
14	Systemic immunity against a murine colon tumor (CT‐26) produced by immunization with syngeneic cells expressing a transfected viral gene product 1989 ·International Journal of Cancer ·Hans K. Schackert, Toshiyuki Itaya, Gabriele Schackert, Eric R. Fearon, Bert Vogelstein, Philip Frost	13
15	Carrier detection in the Wiskott Aldrich syndrome 1988 ·Blood ·(unknown), Donald B. Kohn, (unknown), Bert Vogelstein, R. Michael Blaese	8
16	Amplification units containing human N-myc and c-myc genes. 1986 ·Proceedings of the National Academy of Sciences ·K W Kinzler, Barbara A. Zehnbauer, Garrett M. Brodeur, Robert C. Seeger, J.M. Trent, Paul S. Meltzer, Bert Vogelstein	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact